证券代码：605033 证券简称：美邦股份 公告编号：2025-050 陕西美邦药业集团股份有限公司 关于公司董事离任暨选举职工董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 陕西美邦药业集团股份有限公司（以下简称"公司"或"本公司"）于 2025 年 9 月 26 日召开 2025 年第一次临时股东会，审议通过《关于取消监事会、修订 <公司章程>并办理工商备案登记的议案》。根据《中华人民共和国公司法》《上 海证券交易所上市公司自律监管指引第 1 号——规范运作》等法律法规、规范性 文件及《陕西美邦药业集团股份有限公司章程》的相关规定，并结合公司董事变 动情况，公司于同日召开职工代表大会，选举樊小龙先生为公司第三届董事会职 工代表董事。 一、董事离任情况 | 姓名 | 离任 | 离任时间 | | 原定任期到 | | 离任原因 | 是否继续在 上市公司及 | 具体职务 | 是否存在 未履行完 | | --- | --- | --- | --- | --- | --- | --- | --- | --- ...

2025 年第一次临时股东会 的 法律意见书 国浩律师（上海）事务所 关 于 陕西美邦药业集团股份有限公司 上海市静安区山西北路 99 号苏河湾中心 25-28 楼 邮编：200085 25-28/F, Suhe Centre, 99 North Shanxi Road, Jing'an District, Shanghai, China 电话/Tel: +86 21 5234 1668 传真/Fax: +86 21 5234 1670 网址/Website: http://www.grandall.com.cn 国浩律师（上海）事务所 股东会法律意见书 2025 年 9 月 国浩律师（上海）事务所 关于陕西美邦药业集团股份有限公司 2025 年第一次临时股东会的法律意见书 致：陕西美邦药业集团股份有限公司 陕西美邦药业集团股份有限公司（以下简称"公司"）2025 年第一次临时股东 会于 2025 年 9 月 26 日 15 点在陕西省西安市经济技术开发区草滩三路石羊工业 园区 A19 号楼陕西美邦药业集团股份有限公司三楼会议室召开，国浩律师（上 海）事务所（以下简称"本所"）接受公司的委托，指派刘亚楠律师、 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券代码：605033 证券简称：美邦股份 公告编号：2025-049 陕西美邦药业集团股份有限公司 2025年第一次临时股东会决议公告 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东会召开的时间：2025 年 9 月 26 日 (二)股东会召开的地点：陕西省西安市经济技术开发区草滩三路石羊工业园区 A19 号楼陕西美邦药业集团股份有限公司三楼会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 107 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 98,706,200 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 73.0075 | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东会由董事会召集，以现场投票和网络投票相结合的方式进行表决， 会议由董事长张少武 ...

2025 年第一次临时股东会会议资料 陕西美邦药业集团股份有限公司 二〇二五年第一次临时股东会 会议资料 二〇二五年九月 2025 年第一次临时股东会会议资料 会议须知 为确保陕西美邦药业集团股份有限公司（以下简称"本公司"或"公司"） 股东在本公司 2025 年第一次临时股东会（以下简称"本次会议"）依法行使权 利，保证会议秩序和议事效率，相关事项如下： 六、本次会议结束后，股东如有任何问题或建议，请与本公司董事会秘书办 公室联系。 2025 年第一次临时股东会会议资料 一、公司根据《中华人民共和国公司法》《中华人民共和国证券法》《陕西 美邦药业集团股份有限公司章程》（以下简称"《公司章程》"）及《陕西美邦 药业集团股份有限公司股东会议事规则》规定，认真做好本次会议的各项工作。 二、公司董事会在本次会议过程中，应当认真履行法定职责，维护股东合法 权益。 三、公司股东出席本次会议，依法享有《公司章程》规定的各项权利，并认 真履行法定义务，不得侵犯其他股东的合法权益，不得扰乱本次会议的正常秩序。 四、本次会议议案的表决采取现场记名投票与网络投票相结合的方式投票表 决。本次会议议案全部是采用非累积投票制进行投票： ...

证券代码：605033 证券简称：美邦股份 公告编号：2025-048 陕西美邦药业集团股份有限公司 关于召开2025年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 陕西美邦药业集团股份有限公司（以下简称"公司"）已于 2025 年 8 月 27 日在上海证券交易所网站（www.sse.com.cn）披露了《陕西美邦药业集团股份有 限公司 2025 年半年度报告》及《陕西美邦药业集团股份有限公司 2025 年半年度 会议召开时间：2025 年 09 月 19 日（星期五）15:00-16:00 会议召开地点：价值在线（www.ir-online.cn） 会议召开方式：网络互动方式 会 议 问 题 征 集 ： 投 资 者 可 于 2025 年 09 月 19 日 前 访 问 网 址 https://eseb.cn/1rtAj5lSNmE 或使用微信扫描下方小程序码进行会前提 问，公司将通过本次业绩说明会，在信息披露允许范围内就投资者普遍 关注的问题进行回答。 报告摘要》。为便于广大投资者 ...

Group 1 - A new company named Shaanxi Departure Point Crop Solutions Co., Ltd. has been established, with Huang Zhaozhong as the legal representative [1] - The company's business scope includes research and development of bio-organic fertilizers, compound microbial fertilizers, and biopesticide technology [1] - The company is wholly owned by Meibang Co., Ltd. (stock code: 605033) [1]

Summary of Key Points Core Viewpoint - On September 5, Meibang Co., Ltd. executed a block trade of 144,300 shares, amounting to 2.9986 million yuan, which represented 2.61% of the total trading volume for the day. The transaction price was 20.78 yuan, reflecting a discount of 12.39% compared to the market closing price of 23.72 yuan [1]. Group 1 - The block trade involved a total of 144,300 shares [1]. - The total transaction amount was 2.9986 million yuan [1]. - The transaction price was set at 20.78 yuan per share [1]. Group 2 - The block trade accounted for 2.61% of the total trading volume on that day [1]. - The discount of 12.39% was calculated based on the market closing price of 23.72 yuan [1].

Market Overview - The agricultural chemical sector experienced a decline of 2.2% on September 2, with Sierte leading the drop [1] - The Shanghai Composite Index closed at 3858.13, down 0.45%, while the Shenzhen Component Index closed at 12553.84, down 2.14% [1] Stock Performance - Notable gainers in the agricultural chemical sector included: - Yingtai Biological: Closed at 4.62, up 3.59% with a trading volume of 411,100 shares and a turnover of 188 million [1] - New Agricultural Shares: Closed at 19.88, up 3.11% with a trading volume of 111,800 shares and a turnover of 225 million [1] - Taihe Shares: Closed at 32.07, up 2.66% with a trading volume of 98,100 shares and a turnover of 313 million [1] - Major decliners included: - Sierte: Closed at 5.03, down 7.71% with a trading volume of 714,700 shares and a turnover of 361 million [2] - Xin'an Shares: Closed at 10.71, down 5.56% with a trading volume of 636,200 shares and a turnover of 689 million [2] - Lianhua Technology: Closed at 11.33, down 5.19% with a trading volume of 858,800 shares and a turnover of 989 million [2] Capital Flow - The agricultural chemical sector saw a net outflow of 973 million from institutional investors, while retail investors contributed a net inflow of 728 million [2][3] - Key stocks with significant capital flow included: - Xin'an Shares: Institutional net inflow of 31.48 million, retail net outflow of 37.07 million [3] - New Agricultural Shares: Institutional net inflow of 29.05 million, retail net outflow of 19.80 million [3] - Hong Sifang: Institutional net inflow of 24.48 million, retail net outflow of 29.65 million [3]

Group 1 - The agricultural chemical sector increased by 1.07% on August 29, with Yuntu Holdings leading the gains [1] - The Shanghai Composite Index closed at 3857.93, up 0.37%, while the Shenzhen Component Index closed at 12696.15, up 0.99% [1] - Key stocks in the agricultural chemical sector showed significant price increases, with Yuntu Holdings rising by 3.88% to a closing price of 11.52 [1] Group 2 - The agricultural chemical sector experienced a net outflow of 355 million yuan from institutional investors, while retail investors saw a net inflow of 361 million yuan [2] - Major stocks like Salt Lake Co. and Baiao Chemical had varying net inflows and outflows from different investor types, indicating mixed investor sentiment [3] - Salt Lake Co. had a net inflow of 98.03 million yuan from institutional investors, while it faced a net outflow of 99.10 million yuan from retail investors [3]

Core Insights - Meibang Co., Ltd. reported a total revenue of 485 million yuan for the first half of 2025, a decrease of 4.76% year-on-year, and a net profit attributable to shareholders of 36.14 million yuan, down 23.81% year-on-year [1] - The company's gross profit margin improved to 32.97%, an increase of 8.67% year-on-year, while the net profit margin decreased to 7.45%, down 20.00% year-on-year [1] - The company has a significant amount of accounts receivable, with accounts receivable accounting for 670.04% of the latest annual net profit [14] Financial Performance - Total revenue for 2024 was 510 million yuan, compared to 485 million yuan in 2025, reflecting a decline of 4.76% [1] - Net profit attributable to shareholders decreased from 47.43 million yuan in 2024 to 36.14 million yuan in 2025, a drop of 23.81% [1] - The gross profit margin increased from 30.34% in 2024 to 32.97% in 2025, while the net profit margin fell from 9.31% to 7.45% [1] - Total expenses (selling, administrative, and financial) amounted to 75.33 million yuan, representing 15.52% of revenue, an increase of 24.59% year-on-year [1] Cash Flow and Assets - Operating cash flow per share was -1.58 yuan, a decrease of 45.52% year-on-year [1] - The company experienced a 37.07% decrease in cash and cash equivalents due to the timing of business annual payment settlements [3] - Accounts receivable increased by 327.72% due to the same timing issue regarding payment settlements [6] Liabilities and Investments - Interest-bearing liabilities rose by 91.58%, from 73.08 million yuan to 140 million yuan, due to new long-term borrowings [11] - The company saw a 39.29% decrease in trading financial assets due to a reduction in maturing financial products [4] - Contract liabilities decreased by 84.73% as a result of reduced advance payments [10] Business Model and Strategy - The company's performance is primarily driven by research and marketing efforts, necessitating a thorough examination of the underlying factors [14] - The historical return on invested capital (ROIC) was 3.05%, indicating weak capital returns, with a median ROIC of 17.26% since its listing [13]